SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000850261-18-000017
Filing Date
2018-04-26
Accepted
2018-04-25 21:44:33
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a10-kaproxy.htm 10-K/A 601010
2 EXHIBIT 10.28 ex1028.htm EX-10.28 7705
3 EXHIBIT 31.3 ex313.htm EX-31.3 7794
4 EXHIBIT 31.4 ex314.htm EX-31.4 7873
  Complete submission text file 0000850261-18-000017.txt   625487
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36150 | Film No.: 18775844
SIC: 8731 Services-Commercial Physical & Biological Research